Mesoporous Silica Nanoparticles Deliver Five-miRNA Cocktail to Inhibit HSV-2 Replication

Researchers have developed a method using mesoporous silica nanoparticles to deliver a combination of five specific microRNAs (miRNAs) to inhibit herpes simplex virus type 2 (HSV-2) infection. The study, published in *Scientific Reports*, demonstrates that this nanoparticle-based delivery system effectively suppresses viral replication in laboratory models.

The research team engineered the mesoporous silica nanoparticles to act as carriers for the miRNA cocktail, which targets multiple stages of the HSV-2 life cycle. By utilizing these nanoparticles, the scientists achieved a controlled release of the genetic material into infected cells. The experimental data indicates that the synergistic effect of the five miRNAs significantly reduces the viral load compared to treatments using individual miRNAs or standard delivery methods. The study highlights the potential of this nanotechnology-based approach as a strategy for managing viral infections, noting that the silica structure provides stability and improves the cellular uptake of the therapeutic agents.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: June 9, 2026

Author

GOAI